Gene-editing trial
Researchers in the US have successfully conducted the first small-scale clinical trial to test a gene-editing treatment for cancer. They extracted t-cells, which are immune cells, from three cancer patients and edited their DNA with Crispr-Cas9, a powerful tool which works like molecular scissors to remove with great precision part of the cells’ genetic code…
Details